Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment
Clinical trial NCT07314164 · RECRUITING
Trial details
- NCT number
- NCT07314164
- Sponsor
- Ipsen
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-12-17
- Primary completion
- 2027-10-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.